Abrams’ plan consists of actions that will ensure Georgians who rely on insulin therapies to live have access to the health care services and medications they need by: expanding Medicaid, implementing an Emergency Insulin Program, and demanding federal action to cap the cost of insulin.
In Georgia, more than one million people, or 12.4 percent of the adult population, have been diagnosed with diabetes and approximately 234,000 Georgians have diabetes that is undiagnosed, according to the American Diabetes Association.
Read more about Abrams’ new plan below:
Ledger-Enquirer: Stacey Abrams vows to create statewide insulin safety net, lower prices if elected
June 3, 2022
By Nick Wooten
Democratic candidate Stacey Abrams told the Ledger-Enquirer that she will create a program to provide an emergency, one-month supply of insulin to qualifying Georgians as part of her plan to address access and rising insulin costs if she’s elected governor.
The emergency insulin program would be open to low and moderate-income residents who have gaps in health insurance coverage or who may be unable to pay for their monthly insulin supply due to the loss of a job, a recent move or other circumstances.
Uninsured Georgians will also be eligible. The state would initially allocate $23 million towards the program.
Abrams is expected to discuss the program during visits to Columbus and southwest Georgia in the coming days. Counties in the region have the highest percentage of adults with diabetes statewide. Abrams’ campaign says it’s her first policy rollout of the election.
“Georgians with diabetes should not have to make tough choices about whether to ration or go without their insulin or provide for their families,” Abrams said.
ABRAMS’ INSULIN PLANS
In addition to the emergency program, Abrams is calling for Medicaid expansion and federal action to address insulin prices.
Abrams also called on Congress to pass a bill proposed by fellow Georgia Democrat, U.S. Sen. Raphael Warnock. Warnock’s “Affordable Insulin Now Act” would cap the patient cost of insulin at $35 a month under private insurance and Medicare’s prescription drug benefit.